WallachBeth Capital Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at WallachBeth Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by WallachBeth Capital. Brokerage RankingSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROITotal Ratings0 Last 12 MonthsBuy Ratings0 Last 12 MonthsSell Ratings0 Last 12 Months Country USA (NYSE & NASDAQ) USA (NYSE & NASDAQ)USA (All Exchanges)CanadaUnited Kingdom Sector All Sectors AerospaceAuto/Tires/TrucksBasic MaterialsBusiness ServicesCommunication ServicesComputer and TechnologyConstructionConsumer CyclicalConsumer DefensiveConsumer DiscretionaryConsumer GoodsConsumer StaplesEnergyFinanceFinancial ServicesIndustrialsManufacturingMedicalMiscellaneousMulti-Sector ConglomeratesReal EstateRetail/WholesaleServicesTransportationUtilities Market Cap All MarketCaps Mega Cap (More Than $200B)Large Cap ($10B-$200B)Mid Cap ($2B-$10B)Small Cap ($300M-$2B)Micro Cap ($50M-$300M)Nano Cap (Under $50M) MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Reporting Date Export to Excel CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetailsQUREuniQure$14.45-0.2%12/6/2016 Lower Price Target$27.00 ➝ $15.00Buy00.00%View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/6/2016IRWDIronwood Pharmaceuticals$1.31+0.4%9/27/2016 Boost Price Target$15.00 ➝ $17.00Hold00.00%View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 9/27/2016VTGNVistaGen Therapeutics$2.92+0.3%7/7/2016 Initiated Coverage$510.00Buy00.00%View details for WallachBeth Capital rating of VistaGen Therapeutics (NASDAQ:VTGN) on 7/7/2016ESPREsperion Therapeutics$2.76-0.5%7/5/2016 Downgrade$35.00Buy ➝ Hold00.00%View details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 7/5/2016QUREuniQure$14.45-0.2%6/15/2016 Lower Price Target$60.00 ➝ $35.00Buy00.00%View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 6/15/2016QUREuniQure$14.45-0.2%12/1/2015 Boost Price Target$33.00 ➝ $60.00Buy00.00%View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/1/2015ESPREsperion Therapeutics$2.76-0.5%10/26/2015 Initiated Coverage$34.00Buy00.00%View details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 10/26/2015QUREuniQure$14.45-0.2%8/28/2015 Lower Price Target$35.00 ➝ $33.00Buy00.00%View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/28/2015QUREuniQure$14.45-0.2%8/7/2015 Initiated Coverage$35.00Buy00.00%View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/7/2015GMEDGlobus Medical$56.78-1.8%3/2/2015 Boost Price Target$26.00 ➝ $30.00Buy00.00%View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 3/2/2015 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. IRWDIronwood Pharmaceuticals$1.31+0.4%2/13/2015 Boost Price Target$15.00 ➝ $17.00Hold00.00%View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 2/13/2015TENXTenax Therapeutics$6.24-1.0%11/18/2014 Initiated Coverage$384,000.00Buy00.00%View details for WallachBeth Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 11/18/2014AKTXAkari Therapeutics$0.83+9.5%8/12/2014 Initiated Coverage$340.00Buy00.00%View details for WallachBeth Capital rating of Akari Therapeutics (NASDAQ:AKTX) on 8/12/2014GMEDGlobus Medical$56.78-1.8%8/6/2014 Upgrade$27.00 ➝ $24.00Hold ➝ Buy00.00%View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 8/6/2014INGRIngredion$123.91-1.4%6/18/2014 Initiated Coverage$16.00Hold00.00%View details for WallachBeth Capital rating of Ingredion (NYSE:INGR) on 6/18/2014IRWDIronwood Pharmaceuticals$1.31+0.4%6/18/2014 Initiated Coverage$16.00Hold00.00%View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 6/18/2014WBWeibo$12.75+1.2%5/13/2014 Downgrade$4.00 ➝ $2.50Buy ➝ Hold00.00%View details for WallachBeth Capital rating of Weibo (NASDAQ:WB) on 5/13/2014GMEDGlobus Medical$56.78-1.8%2/27/2014 Downgrade$23.00 ➝ $27.00Buy ➝ Hold00.00%View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 2/27/2014GMEDGlobus Medical$56.78-1.8%5/17/2013 Initiated Coverage$19.00Buy00.00%View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 5/17/2013LHLabcorp$276.05+0.7%4/12/2013 Downgrade$97.00Buy ➝ Hold00.00%View details for WallachBeth Capital rating of Labcorp (NYSE:LH) on 4/12/2013TMOThermo Fisher Scientific$471.65-1.9%4/4/2013 Downgrade$68.00 ➝ $76.00Buy ➝ Hold00.00%View details for WallachBeth Capital rating of Thermo Fisher Scientific (NYSE:TMO) on 4/4/2013BMYBristol Myers Squibb$46.03-0.7%3/25/2013 DowngradeBuy ➝ Hold00.00%View details for WallachBeth Capital rating of Bristol Myers Squibb (NYSE:BMY) on 3/25/2013UHSUniversal Health Services$187.69+0.8%3/4/2013 Downgrade$61.00Buy ➝ Hold00.00%View details for WallachBeth Capital rating of Universal Health Services (NYSE:UHS) on 3/4/2013JAZZJazz Pharmaceuticals$129.97+2.7%2/27/2013 Boost Price Target$63.00 ➝ $70.00Buy00.00%View details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/27/2013HCAHCA Healthcare$400.26+0.1%2/6/2013 Boost Price Target$31.00 ➝ $36.00Hold00.00%View details for WallachBeth Capital rating of HCA Healthcare (NYSE:HCA) on 2/6/2013WATWaters$304.01+0.3%1/28/2013 Upgrade$87.00 ➝ $103.00Hold ➝ Buy00.00%View details for WallachBeth Capital rating of Waters (NYSE:WAT) on 1/28/2013IRWDIronwood Pharmaceuticals$1.31+0.4%1/16/2013 Boost Price Target$10.00 ➝ $13.00Hold00.00%View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 1/16/2013BMYBristol Myers Squibb$46.03-0.7%1/8/2013 Boost Price Target$44.50 ➝ $49.50Buy00.00%View details for WallachBeth Capital rating of Bristol Myers Squibb (NYSE:BMY) on 1/8/2013IRWDIronwood Pharmaceuticals$1.31+0.4%12/18/2012 Initiated CoverageHold00.00%View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 12/18/2012LHLabcorp$276.05+0.7%11/13/2012 Upgrade$91.00 ➝ $97.00Hold ➝ Buy00.00%View details for WallachBeth Capital rating of Labcorp (NYSE:LH) on 11/13/2012ESEversource Energy$63.59+0.3%11/13/2012 Boost Price Target$3.50 ➝ $5.00Hold00.00%View details for WallachBeth Capital rating of Eversource Energy (NYSE:ES) on 11/13/2012MYGNMyriad Genetics$7.41-1.1%10/1/2012 Initiated Coverage$31.00Buy00.00%View details for WallachBeth Capital rating of Myriad Genetics (NASDAQ:MYGN) on 10/1/2012HSICHenry Schein$67.68-1.0%9/6/2012 Initiated CoverageHold00.00%View details for WallachBeth Capital rating of Henry Schein (NASDAQ:HSIC) on 9/6/2012BMYBristol Myers Squibb$46.03-0.7%9/4/2012 Initiated Coverage$41.00Buy00.00%View details for WallachBeth Capital rating of Bristol Myers Squibb (NYSE:BMY) on 9/4/2012MTDMettler-Toledo International$1,270.19-0.5%8/28/2012 Initiated Coverage$173.00Hold00.00%View details for WallachBeth Capital rating of Mettler-Toledo International (NYSE:MTD) on 8/28/2012LHLabcorp$276.05+0.7%8/27/2012 Initiated Coverage$91.00Hold00.00%View details for WallachBeth Capital rating of Labcorp (NYSE:LH) on 8/27/2012DGXQuest Diagnostics$182.23+1.2%8/27/2012 Initiated CoverageHold00.00%View details for WallachBeth Capital rating of Quest Diagnostics (NYSE:DGX) on 8/27/2012JAZZJazz Pharmaceuticals$129.97+2.7%8/27/2012 Initiated Coverage$63.00Buy00.00%View details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 8/27/2012 MarketBeat Community Rating for WallachBeth CapitalCommunity Ranking: 2.6 out of 5 (2.6 of 5 stars)Outperform Votes: 53,314 (Vote Outperform)Underperform Votes: 50,896 (Vote Underperform)Total Votes: 104,210MarketBeat's community ratings are surveys of what our community members think about WallachBeth Capital and other research firms. Vote "Outperform" if you believe WallachBeth Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WallachBeth Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
